top of page

OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION

Wed, Apr 22

|

Webinar - Meeting ID 200422-BMS-54768

Registration is Closed
See other events
OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION
OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION

Time & Location

Apr 22, 2020, 6:00 PM

Webinar - Meeting ID 200422-BMS-54768

Guests

About The Event

You are cordially invited by your Bristol-Myers Squibb representative to attend a presentation that will focus on:

OVERVIEW OF IMMUNE-RELATED ADVERSE EVENTS CAUSED BY IMMUNE CHECKPOINT INHIBITION

Program Information:

You have been cordially invited by

Jeffrey Read

Meeting ID:

200422-BMS-54768

To RSVP, please call 1-866-326-7600 during the hours of 8:30am to 5:00pm EST,

Wednesday, April 22, 2020 6:00 PM - EST

Virtual Attendee 1000 Wyckoff Ave

Mahwah, New Jersey 07430 (201) 560-5635

Program Faculty:

Jay Patel, PharmD, BCOP Immuno-Oncology Clinical Liaison Bristol-Myers Squibb

Share This Event

bottom of page